SciLex Pharmaceuticals, Inc.

Clinical trials sponsored by SciLex Pharmaceuticals, Inc., explained in plain language.

Now part of Scilex Holding Company SCLX NASDAQ

A specialty pharmaceutical company developing pain management products.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Completed 1

New skin patch could ease acute back pain without pills

Symptom relief Completed

This study tests whether a medicated skin patch called SP-103 can reduce pain and disability in people with moderate to severe acute lower back pain. Participants wear the patch for 12 hours daily over 28 days. The trial compares the active patch to a placebo patch to see if it t…

Phase 2 • Sponsor: Scilex Pharmaceuticals, Inc. • Aim: Symptom relief

Last updated Jul 08, 2026 00:00 UTC

SciLex Pharmaceuticals, Inc.

New skin patch could ease acute back pain without pills